Table 5. Univariate analysis of potential factors affecting PFS.
| Variables | HR (95% CI) | P |
|---|---|---|
| NLR (<2.57/≥2.57) | 3.959 (2.083–7.525) | <0.001 |
| Gender (male/female) | 0.964 (0.545–1.704) | 0.898 |
| Smoking (never-smoker/current or ex-smoker) | 2.32 (1.214–4.434) | 0.011 |
| Age (≤65/>65 years) | 1.448 (0.795–2.638) | 0.226 |
| Pathological type (squamous carcinoma/adenocarcinoma) | 0.302 (0.143–0.638) | 0.002 |
| TNM staging (stage III/IV) | 1.174 (0.544–2.536) | 0.682 |
| Tumor Differentiation (well/moderately/poorly) | 0.863 (0.550–1.353) | 0.520 |
NLR, neutrophil-to-lymphocyte ratio; PFS, progression-free survival; TNM, The TNM Classification of Malignant Tumors.